These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 29728940)

  • 1. Systemic Therapies for Advanced Squamous Cell Anal Cancer.
    Sclafani F; Rao S
    Curr Oncol Rep; 2018 May; 20(7):53. PubMed ID: 29728940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Metastatic squamous cell carcinomas of the anal canal: Current management and prospects].
    Saint A; Evesque L; François É
    Bull Cancer; 2020; 107(7-8):792-799. PubMed ID: 32591138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent metastatic anal cancer treated with modified paclitaxel, ifosfamide, and cisplatin and third-line mitomycin/cetuximab.
    Khawandanah M; Baxley A; Pant S
    J Oncol Pharm Pract; 2015 Jun; 21(3):232-7. PubMed ID: 24627343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Squamous cell anal carcinoma. What's next ?].
    Kim S; Spehner L; Cabel L; Bidard FC; Borg C
    Bull Cancer; 2021 Jan; 108(1):80-89. PubMed ID: 33423780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study.
    Kim S; François E; André T; Samalin E; Jary M; El Hajbi F; Baba-Hamed N; Pernot S; Kaminsky MC; Bouché O; Desrame J; Zoubir M; Ghiringhelli F; Parzy A; De La Fouchardiere C; Smith D; Deberne M; Spehner L; Badet N; Adotevi O; Anota A; Meurisse A; Vernerey D; Taieb J; Vendrely V; Buecher B; Borg C
    Lancet Oncol; 2018 Aug; 19(8):1094-1106. PubMed ID: 30042063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second-line treatment after docetaxel, cisplatin and 5-fluorouracil in metastatic squamous cell carcinomas of the anus. Pooled analysis of prospective Epitopes-HPV01 and Epitopes-HPV02 studies.
    Stouvenot M; Meurisse A; Saint A; Buecher B; André T; Samalin E; Jary M; El Hajbi F; Baba-Hamed N; Pernot S; Kaminsky MC; Bouché O; Desrame J; Zoubir M; Smith D; Ghiringhelli F; Parzy A; de la Fouchardiere C; Almotlak H; Vienot A; Jacquin M; Taieb J; Nguyen T; Vernerey D; Borg C; Kim S
    Eur J Cancer; 2022 Feb; 162():138-147. PubMed ID: 34995900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platinum-Fluoropyrimidine and Paclitaxel-Based Chemotherapy in the Treatment of Advanced Anal Cancer Patients.
    Sclafani F; Morano F; Cunningham D; Baratelli C; Kalaitzaki E; Watkins D; Starling N; Chau I; Rao S
    Oncologist; 2017 Apr; 22(4):402-408. PubMed ID: 28209745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docetaxel, Cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: a phase II study of French interdisciplinary GERCOR and FFCD groups (Epitopes-HPV02 study).
    Kim S; Jary M; André T; Vendrely V; Buecher B; François E; Bidard FC; Dumont S; Samalin E; Peiffert D; Pernot S; Baba-Hamed N; El Hajbi F; Bouché O; Desrame J; Parzy A; Zoubir M; Louvet C; Bachet JB; Nguyen T; Abdelghani MB; Smith D; De La Fouchardière C; Aparicio T; Bennouna J; Gornet JM; Jacquin M; Bonnetain F; Borg C
    BMC Cancer; 2017 Aug; 17(1):574. PubMed ID: 28841909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Telomerase CD4
    Spehner L; Kim S; Vienot A; François E; Buecher B; Adotevi O; Vernerey D; Abdeljaoued S; Meurisse A; Borg C
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of anal cancer in 2010. Part 2: current treatment standards and future directions.
    Abbas A; Yang G; Fakih M
    Oncology (Williston Park); 2010 Apr; 24(5):417-24. PubMed ID: 20480740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor receptor inhibition in metastatic anal cancer.
    Rogers JE; Ohinata A; Silva NN; Mehdizadeh A; Eng C
    Anticancer Drugs; 2016 Sep; 27(8):804-8. PubMed ID: 27272412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-associated anal squamous cell cancer: an otherwise preventable disease.
    Konstantinopoulos PA; Schlecht HP; Bryan B; Pantanowitz L; Dezube BJ
    J Clin Oncol; 2006 Sep; 24(27):4516-7. PubMed ID: 16983122
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemotherapy, "Lighting the Fire" or "Releasing the Brakes" in Metastatic Anal Cancer.
    Glynne-Jones R
    Dis Colon Rectum; 2017 Aug; 60(8):757-758. PubMed ID: 28682960
    [No Abstract]   [Full Text] [Related]  

  • 14. New approaches in palliative systemic therapy of anal squamous cell carcinoma.
    Lohynská R; Pechačová Z
    Klin Onkol; 2022; 35(3):190-194. PubMed ID: 35760571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of advanced anal cancer].
    Norum J; Wist E
    Nord Med; 1992; 107(8-9):227-8. PubMed ID: 1408730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Immunotherapy in the Treatment of Anal Cancer and Future Strategies.
    Jácome AA; Morris VK; Eng C
    Curr Treat Options Oncol; 2022 Aug; 23(8):1073-1085. PubMed ID: 35666353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-agent paclitaxel in advanced anal cancer after failure of cisplatin and 5-fluorouracil chemotherapy.
    Abbas A; Nehme E; Fakih M
    Anticancer Res; 2011 Dec; 31(12):4637-40. PubMed ID: 22199342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anal squamous cell carcinoma: standards of care, new data and ongoing clinical trials.
    Giunta EF; Bregni G; Hendlisz A; Sclafani F
    Curr Opin Oncol; 2021 Jul; 33(4):372-377. PubMed ID: 33882526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy in head and neck cancer: aiming at EXTREME precision.
    Szturz P; Vermorken JB
    BMC Med; 2017 Jun; 15(1):110. PubMed ID: 28571578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anal cancer treatment: current status and future perspectives.
    Ghosn M; Kourie HR; Abdayem P; Antoun J; Nasr D
    World J Gastroenterol; 2015 Feb; 21(8):2294-302. PubMed ID: 25741135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.